RYNEX PSE is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Edwards Pharmaceuticals, Inc.. The primary component is Brompheniramine Maleate; Pseudoephedrine Hydrochloride.
Product ID | 0485-0206_19ac8a3a-6e5f-4c5d-93f0-9aba74ef22f6 |
NDC | 0485-0206 |
Product Type | Human Otc Drug |
Proprietary Name | RYNEX PSE |
Generic Name | Brompheniramine Maleate And Pseudoephedrine Hydrochloride |
Dosage Form | Liquid |
Route of Administration | ORAL |
Marketing Start Date | 2011-03-07 |
Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
Application Number | part341 |
Labeler Name | EDWARDS PHARMACEUTICALS, INC. |
Substance Name | BROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE |
Active Ingredient Strength | 1 mg/5mL; mg/5mL |
Pharm Classes | Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2011-03-07 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | OTC monograph final |
Application Number | part341 |
Product Type | HUMAN OTC DRUG |
Billing Unit | ML |
Marketing Start Date | 2011-03-07 |
Inactivation Date | 2020-01-31 |
Reactivation Date | 2020-04-08 |
Ingredient | Strength |
---|---|
BROMPHENIRAMINE MALEATE | 1 mg/5mL |
SPL SET ID: | 2f2d9b5a-f66b-4928-8d43-402ef9efcfdf |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |